Endometrial cancer: factors affecting survival

Purpose: To evaluate the influence in survival of clinical and pathological findings in patients with endometrial cancer.

Methods: In 152 women treated for endometrial cancer from 1982 to 1996, personal, obstetrical and oncological data, histology, grade, myometrial invasion, peritoneal cytology, FIGO stage and treatment were correlated with survival.

Results: Mean age was of 60.3 +/- 11.1 years old. Eight patients had a previous history of other neoplasms (seven of them gynecological). The mean clinical complaint was abnormal uterine bleeding. The most common histological type was endometrioid (84.9%), only 51 cases did not show myometrial invasion and 119 women were in Stage I at diagnosis. Peritoneal cytology was negative in 113 patients. Seven patients out of 85 in whom lymphadenectomy was performed showed metastasis. Seventeen of the patients died. The factors influencing survival were age, myometrial invasion and lymph node metastasis.

Conclusion: Lack of myometrial invasion, absence of lymph node metastasis and age younger than 60 years seem to be the most significant predicting factors of survival.

Endometrial cancer; Survival

[1] Kneale B.L., Giles G.G.: "Endometrial cancer: trends in incidence and survival: a preventable disease?". Aust. N. Z. J. Obstet. Gynaecol., 1993, 33 (1), 1.

[2] Tabernero J.M., Alonso M.C., Ojeda B. et al.: "Endometrial cancer stages I and 11. Analysis of survival and prognostic factors". Eur. J. Gynaecol. Oncol., 1995, 16 (1), 18.

[3] Viladiu P., Izquierdo A., Marcos R. et al.: "El c的cer a Girona, 194-1997". Barcelona: Unitat d'Epidemiologia i Registre de Cancer a Girona, 2000.

[4] International Agency for Research on Cancer: "Trends in cancer incidence and mortality". Lyon: !ARC Scientific Publicactions no. 121, 1993.

[5] Ministerio de Sanidad y Consumo: "Cancer en Espana". Madrid, Ministerio de Sanidad y Consumo, 1993.

[6] FIGO Annual Report on the Results of Treatment in Gynecological Cancer. J. Epidemiol. Biostat., 2001, 6 (1), 45.

[7] Beard C.M., Hartmann L.C., Keeney G.L. et al.: "Endometrial cancer in Olmsted County, MN: trends in incidence, risk factors and survival". Ann. Epidemiol., 2000, 10 (2), 97.

[8] Sigurdsson K., Sigurdardottir B., Steinsson S., Benediktsdottir K., Sigurvinsson T., Sigvaldason H.: "Survival and prognostic factors eof endometrial cancer patients in Iceland 1964-85: can attendance at pupulation-based Pap-smear screening affect population'l". Int. J. Cancer, 1998, 79 (2), 166.

[9] Schaffer P.: "Epidemiology of cervical and endoemtrial cancer" Bull. Acad. Natl. Med., 1997, 181 (7), 1347.

[10] Chaplain G., Cuisenier J., Milan C. et al.: "Cancers of the corpus uteri on the Cote-d' Or I 982-1990. Incidence, clinical stage and survival". Bull. Cancer, 1994, 81 (8), 691.

[11] Gatta G., Lasota M.B., Verdecchia A.: "Survival of European women with gynaecological tumors during the period 1978-1989 EUROCARE Working Group". Eur. J. Cancer, 1998, 34, 2218.

[12] Montella M., Maffeo A.. De Marco M.R., Gallo M.S., Romeo F., Ventura R.: "Epidemiology and survival of endometrial cancer". Eur. J. Gynaec. Oncol., 1995, 16 (4), 310.

[13] Eltabbakh G.H., Moore A.D.: "Survival of women with surgical stage II endometrial camcer''. Gynecol. Oneal., 1999, 74 (1), 80.

[14] Behbakht K., Yordan E.L., Casey C. et al.: "Prognostic indicators of survival in advanced endometrial cancer". Gynecol. Oneal., 1994, 55, 363.

[15] Parslov M., Lidegaard 0., Klintorp S. et al.: "Risk factors among young women with endometrial cancer: a Danish case-control study". Am. J. Ohstet. Gynecol.. 2000, 182, 23.

[16] Parazzini F., La Vecchia C., Moroni S., Chatenoud L., Ricci E.: "Family history and the risk of endometrial cancer". Int. J. Cancer, 1994, 59 (4), 46.

[17] Hachisuga T., Fukuda K., Hirakawa T., Kawarabayashi T.: "The effect of nulliparity on survival in endometrial cancer at different ages". Gynecol. Oncol., 2001, 82 (1), 122.